Bank of America Corp DE Sells 188,063 Shares of Cabot Co. (NYSE:CBT)

Bank of America Corp DE cut its stake in Cabot Co. (NYSE:CBTFree Report) by 11.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,479,125 shares of the specialty chemicals company’s stock after selling 188,063 shares during the quarter. Bank of America Corp DE owned about 2.73% of Cabot worth $135,059,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. R Squared Ltd purchased a new position in shares of Cabot during the 4th quarter worth about $26,000. EverSource Wealth Advisors LLC boosted its position in shares of Cabot by 37.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock valued at $74,000 after buying an additional 219 shares during the period. GAMMA Investing LLC grew its stake in shares of Cabot by 10.7% during the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock valued at $123,000 after buying an additional 130 shares during the last quarter. Manchester Capital Management LLC raised its holdings in shares of Cabot by 1,685.1% in the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock worth $153,000 after buying an additional 1,584 shares during the period. Finally, KBC Group NV lifted its stake in shares of Cabot by 43.1% during the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock worth $187,000 after acquiring an additional 616 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CBT. StockNews.com downgraded Cabot from a “buy” rating to a “hold” rating in a research report on Wednesday. JPMorgan Chase & Co. decreased their price objective on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, February 21st. Finally, UBS Group dropped their target price on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a research note on Monday, April 7th.

Read Our Latest Report on CBT

Cabot Stock Performance

CBT stock opened at $73.93 on Friday. Cabot Co. has a 1-year low of $71.64 and a 1-year high of $117.46. The business has a 50-day moving average price of $80.15 and a 200 day moving average price of $91.27. The company has a market capitalization of $4.01 billion, a P/E ratio of 9.82, a PEG ratio of 0.74 and a beta of 0.91. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.04. The firm had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $1.02 billion. Cabot had a net margin of 10.60% and a return on equity of 26.79%. The company’s revenue was down 8.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.78 EPS. As a group, equities research analysts forecast that Cabot Co. will post 7.57 EPS for the current fiscal year.

Cabot Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.43%. This is a positive change from Cabot’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Friday, May 30th. Cabot’s payout ratio is presently 23.29%.

Cabot Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Recommended Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.